China A Key Driver Of Roche’s International Growth
This article was originally published in PharmAsia News
Executive Summary
China market remains strong in sales of both pharma and diagnostics for Roche under expectation, with strategic approval and additional reimbursement of several oncology products in the country. During the most recent trip to Shanghai, the group’s chairman expressed the hope to deepen the collaboration with the locals.